AakhusT.SommerfeltS. ChrStormorkenH.DahlströmK.: Tolerance and excretion of iohexol after intravenous injection in healthy volunteers. Preliminary report. Acta radiol. (1980) Suppl. No. 362, p. 131.
2.
AbeS.ItohM.UnakamiH.KobayashiT. (a): Sinus slowing produced by intracoronary arterial injections of hyperosmotic solutions in man. Amer. Heart J.91 (1976), 339.
3.
AbeS.ItohM.UnakamiH.KobayashiT.KameiT.OhyamaK.KasedaN.UnakamiH. (b): Effects of coronary arteriography on atrioventricular conduction. Studies with His bundle electrography. Amer. Heart J.91 (1976), 203.
4.
AdamsD. F.PaulinS.: Effect of radiographic contrast media in selective injections into the sinus node artery. An experimental study in dogs. Radiology91 (1968), 719.
5.
AlménT.AspelinP.NilssonP.: Aortic and pulmonary arterial pressure after injection of contrast media into the right atrium of the rabbit. Comparison between metrizoate, ioxaglate and iohexol. Acta radiol. (1980) Suppl. No. 362, p. 37.
6.
AlménT.BoijsenE.LindellS. E.: Metrizamide in angiography. I. Femoral angiography. Acta radiol. Diagnosis18 (1977), 33.
7.
AndrewE.DahlstrømK.SveenK.RenaaT.: Amipaque® (metrizamide) in vascular use and use in body cavities. A survey of the initial clinical trials. Invest. Radiol.16 (1981), 455.
8.
ArbogastR.SolignacA.BourassaM. G.: Influence of aortocoronary saphenous vein bypass surgery on left ventricular volumes and ejection fraction. Comparison before and one year after surgery in 51 patients. Amer. J. Med.54 (1973), 290.
CumberlandD. C.: Amipaque in coronary angiography and left ventriculography. Brit. J. Radiol.54 (1981), 203.
11.
DavilaJ. C.SanmarcoM. E.: An analysis of the fit of mathematical models applicable to the measurement of left ventricular volume. Amer. J. Cardiol.18 (1966), 31.
12.
EngeI.Nitter-HaugeS.AndrewE.LevorstadK.: Amipaque, A new contrast medium in coronary angiography. Report of a double-blind study in man. Radiology125 (1977), 317.
13.
EriksonU.CullhedI.HelmiusG.RuhnG.: Erfahrungen mit Amipaque® und Isopaque Coronar® bei der Koronararteriographie. Ein Vergleich. In: Amipaque Workshop. Klinische Erfahrungen mit dem ersten nichtionischen Röntgenkontrastmittel, p. 108. Edited by FrommholdW.HackerH.SchmittH. E.VogelsangH.Excerpta Medica, Amsterdam1978.
14.
FischerH. W.MorrisT. W.: Possible factors in intravascular contrast media toxicity. Invest. Radiol.15 (1980) Suppl., p. 232.
15.
FischerH. W.MorrisT. W.ThomsonK. R.: Contrast media in coronary arteriography. A review. Invest. Radiol.13 (1978), 450.
16.
GensiniG. G.KellyA. E.: Incidence and progression of coronary artery disease. An angiographic correlation in 1263 patients. Arch. intern. Med.129 (1972), 814.
HabereyM.SchröderG.MannesmannG.: Cardiovascular effects of iohexol in the rat and the isolated rabbit heart. Acta radiol. (1980) Suppl. No. 362, p. 29.
19.
HigginsC. B.: Effects of contrast media on the conducting system of the heart. Mechanism of action and identification of toxic component. Radiology124 (1977), 599.
20.
HigginsC. B. (a): Overview and methods used for the study of the cardiovascular actions of contrast materials. Invest. Radiol.15 (1980) Suppl., p. 188.
21.
HigginsC. B. (b): Effects of contrast materials on left ventricular function. Invest. Radiol.15 (1980) Suppl., p. 220.
22.
HigginsC. B.FeldG. K.: Direct chronotropic and dromotropic actions of contrast media. Ineffectiveness of atropine in the prevention of bradyarrhythmias and conduction disturbances. Radiology121 (1976), 205.
23.
FeldG. K.SchmidtW.: Direct and reflex myocardial effects of intracoronary administered contrast materials in the anesthetized and conscious dog. Comparison of standard and newer contrast materials. Invest. Radiol.13 (1978), 205.
24.
JudkinsM. P.: Selective coronary arteriography. Part I. A percutaneous transfemoral technic. Radiology89 (1967), 815.
25.
LangJ. H.LasserE. C.: Nonspecific inhibition of enzymes by organic contrast media. J. Med. Chem.14 (1971), 233.
26.
LehmannE. L.: Nonparametrics. Statistical methods based on ranks. Holden-Day, Inc., McGraw-Hill, San Fransisco1975.
27.
LevorstadK.VatneK.SimonsenS.Nitter-HaugeS.AndrewE.: Amipaque in cardioangiography in ‘high risk’ coronary artery disease patients. A double blind comparison with Isopaque Coronar. In press. (1982).
28.
LevorstadK.VatneK.SimonsenS.Nitter-HaugeS.AndrewE.KolbenstvedtA.KolmannskogF.SommerfeltS. ChrStormorkenH.AndrewE.SveenK.: Tolerability of iohexol after injection into healthy volunteers. To be published in Acta radiol. Diagnosis24 (1983).
29.
LindgrenE. (Editor): Iohexol. A non-ionic contrast medium. Pharmacology and toxicology. Acta radiol. (1980) Suppl. No. 362.
Metrizamide. A non-ionic water-soluble contrast medium. Experimental and preliminary clinical investigations. Acta radiol. (1973) Suppl. No. 335.
32.
MooreE. N.SpearJ. F.: Ventricular fibrillation threshold. Its physiological and pharmacological importance. Arch. intern. Med.135 (1975), 446.
33.
MützelW.SiefertH.-M.SpeckU.: Biochemical-pharmacologic properties of iohexol. Acta radiol. (1980) Suppl. No. 362, p. 111.
34.
NewellJ. D.HigginsC. B.KelleyM. J.GreenC. E.SchmidtW. S.HaiglerF.: The influence of hyperosmolality on left ventricular contractile state. Disparate effects of nonionic and ionic solutions. Invest. Radiol.15 (1980), 363.
35.
Nitter-HaugeS.LevorstadK.: Does aortocoronary saphenous vein bypass surgery change the native coronary arteries? An angiographic follow-up of 60 patients. Acta med. scand.207 (1980), 189.
36.
OlssonB.AulieÅ.SveenK.AndrewE.: Human pharmacokinetics of iohexol. A new non-ionic contrast medium. Accepted for publication in Invest. Radiol.
37.
PopioK. A.RossA. M.OravecJ. M.IngramJ. T.: Identification and description of separate mechanisms for two components of Renogafin cardiotoxicity. Circulation58 (1978), 520.
38.
SalvesenS.FreyK.: Protein binding of metrizamide and the effect on various enzymes. Acta radiol. (1973) Suppl. No. 335, p. 247.
39.
SalvesenS.FreyK.NilsenP. L.HoltermannH.: Ameliorating effect of calcium and magnesium ions on the toxicity of Isopaque sodium. II. Studies on the isolated heart and auricles of the rabbit. Acta radiol. (1967) Suppl. No. 270, p. 30.
40.
SchmittH. E.BurkartF.BertelO.: Laevokardiographie mit Metrizamid. In: Amipaque Workshop. Klinische Erfahrungen mit dem ersten nichtionischen Röntgenkontrastmittel, p. 115. Edited by FrommholdW.HackerH.SchmittH. E.VogelsangH.Excerpta Medica, Amsterdam1978.
41.
SelinK.BjörkL.: Two new contrast media in coronary angiography. A double blind study in patients with coronary artery disease. Acta radiol. Diagnosis24 (1983), 37.
42.
TrägårdhB. (a): Coronary angiography with iohexol and other contrast media in the dog. I. Electrocardiographic alterations. Acta radiol. (1980) Suppl. No. 362, p. 17.
43.
TrägårdhB. (b): Coronary angiography with iohexol and other contrast media in the dog. II. Left ventricular contractility and work. Acta radiol. (1980) Suppl. No. 362, p. 21.
44.
TrägårdhB.CederlundC.-G.: Coronary angiography with iohexol and other contrast media in the dog. III. Contractility of the left ventricle. Acta radiol. (1980) Suppl. No. 362, p. 25.
45.
CederlundC.-G.AlménT.LynchP. (a): Addition of calcium or other cations and of oxygen to ionic and non-ionic contrast media. Effects on cardiac function during coronary arteriography. Invest. Radiol.10 (1975), 231.
46.
AlménT.LynchP. R.VinciguerraT. (b): Effects of metrizamide, a new nonionic contrast medium, on cardiac function during coronary angiography in the dog. Radiology115 (1975), 59.
47.
LynchP. R.VinciguerraT.BoveA. A.LynchP. R. (a): Mechanism of production of cardiac conduction abnormalities due to coronary arteriography in dogs. Invest. Radiol.11 (1976), 563.
48.
BoveA. A.LynchP. R.LynchP. R.VinciguerraT. (b): Cardiac function during coronary arteriography with calcium enriched diatrizoate and metrizamide. Invest. Radiol.11 (1976), 569.
49.
WolfG. L.Le VeenR. F.MulryC.KilzerK. (a): The influence of contrast media additives upon ventricular fibrillation thresholds during coronary angiography in ischemic and normal canine hearts. Cardiovasc. Intervent. Radiol.4 (1981), 145.
50.
WolfG. L.Le VeenR. F.MulryC.KilzerK.MulryC. S.KilzerK.LaskiP. A. (b): New angiographic agents with less fibrillatory propensity. Invest. Radiol.16 (1981), 320.